Vertex Pharmaceuticals Incorporated (BIT:1VRTX)

Italy flag Italy · Delayed Price · Currency is EUR
400.35
0.00 (0.00%)
At close: Jul 22, 2025, 5:30 PM CET
Market Cap102.86B
Revenue (ttm)10.27B
Net Income (ttm)-914.93M
Shares Outn/a
EPS (ttm)-3.55
PE Ration/a
Forward PE24.61
Dividendn/a
Ex-Dividend Daten/a
Volumen/a
Average Volume4
Open400.35
Previous Close400.35
Day's Range400.35 - 400.35
52-Week Range369.50 - 486.10
Betan/a
RSI58.07
Earnings DateAug 4, 2025

About Vertex Pharmaceuticals

Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis (CF). It markets TRIKAFTA/KAFTRIO for people with CF with at least one F508del mutation for 2 years of age and older; ALYFTREK for the treatment for people with CF 6 years of age and older; SYMDEKO/SYMKEVI for treatment of patients with CF 6 years of age and older; ORKAMBI for CF patients 1 year or older; and KALYDECO for the treatment of patients with 1 month or older who have CF with ivacaftor. The com... [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 1989
Employees 6,100
Stock Exchange Borsa Italiana
Ticker Symbol 1VRTX
Full Company Profile

Financial Performance

Financial numbers in USD Financial Statements

News

There is no news available yet.